TD Asset Management’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,957
| Closed | -$3.72M | – | 1517 |
|
|
2022
Q3 | $3.72M | Buy |
14,957
+237
| +2% | +$59K | ﹤0.01% | 822 |
|
|
2022
Q2 | $3.64M | Sell |
14,720
-650
| -4% | -$161K | ﹤0.01% | 845 |
|
|
2022
Q1 | $5.09M | Buy |
15,370
+100
| +0.7% | +$33.1K | ﹤0.01% | 817 |
|
|
2021
Q4 | $5.49M | Sell |
15,270
-665
| -4% | -$239K | ﹤0.01% | 842 |
|
|
2021
Q3 | $5.19M | Buy |
15,935
+74
| +0.5% | +$24.1K | 0.01% | 807 |
|
|
2021
Q2 | $5.19M | Buy |
15,861
+116
| +0.7% | +$38K | 0.01% | 816 |
|
|
2021
Q1 | $5.02M | Buy |
15,745
+46
| +0.3% | +$14.7K | 0.01% | 819 |
|
|
2020
Q4 | $5.09M | Buy |
15,699
+2,946
| +23% | +$955K | 0.01% | 782 |
|
|
2020
Q3 | $3.53M | Buy |
12,753
+3,914
| +44% | +$1.08M | ﹤0.01% | 796 |
|
|
2020
Q2 | $2.14M | Sell |
8,839
-252
| -3% | -$60.9K | ﹤0.01% | 863 |
|
|
2020
Q1 | $1.32M | Sell |
9,091
-74,507
| -89% | -$10.8M | ﹤0.01% | 930 |
|
|
2019
Q4 | $14.3M | Buy |
83,598
+45,944
| +122% | +$7.84M | 0.02% | 459 |
|
|
2019
Q3 | $6.7M | Buy |
37,654
+8,551
| +29% | +$1.52M | 0.01% | 621 |
|
|
2019
Q2 | $7.58M | Buy |
29,103
+407
| +1% | +$106K | 0.01% | 588 |
|
|
2019
Q1 | $8.2M | Buy |
28,696
+9,360
| +48% | +$2.67M | 0.01% | 569 |
|
|
2018
Q4 | $6.29M | Buy |
19,336
+6,661
| +53% | +$2.17M | 0.01% | 599 |
|
|
2018
Q3 | $5.7M | Buy |
12,675
+396
| +3% | +$178K | 0.01% | 690 |
|
|
2018
Q2 | $5.02M | Buy |
+12,279
| New | +$5.02M | 0.01% | 701 |
|